BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide
May 26, 2022 09:08 ET
|
BioSig Technologies, Inc.
Westport, CT, May 26, 2022 (GLOBE NEWSWIRE) -- Commercial pipeline to include 30 advanced leads at Medical Centers of Excellence Company’s development and operational infrastructure...
BioSig’s PURE EP™ System to be Featured During EPLive 2022
May 25, 2022 09:47 ET
|
BioSig Technologies, Inc.
Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering...
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
May 11, 2022 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- To date, Company's FDA 510(k) cleared PURE EP(TM) system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the...
BioSig to Present at Heart Rhythm 2022
April 19, 2022 09:10 ET
|
BioSig Technologies, Inc.
Westport, CT, April 19, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
BioSig to Present at NobleCon18 Capital Markets Conference
April 07, 2022 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services
March 29, 2022 10:06 ET
|
BioSig Technologies, Inc.
Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Announces Closing of Public Offering of Common Stock
March 23, 2022 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, March 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Technologies, Inc. Announces $3 Million Financing with Family Office
March 22, 2022 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, March 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer
March 16, 2022 09:00 ET
|
BioSig Technologies, Inc.
Westport, CT, March 16, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Global Precision Cardiology Industry 2021-2031: Focus on Offering, Sample, Technology, Application, End-user, and Region
February 28, 2022 06:28 ET
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Precision Cardiology Market - A Global and Regional Analysis: Focus on Offering, Sample, Technology, Application, End User, and Region - Analysis and...